Well, i want expecting a 30% run in the first 15 minutes, but I'm glad people see the value here. I believe the company has everything they need to be successful.
how would the market react as per your experience? as net profit would still be negative 4-5m. market follows EPS in the long run, 24-->100m, means it will show 4x profit. Do we have Rocket Doctor bottom profit numbers or only revenue . we dont how much cost rocket doctor will have which will come here in consolidated financials? just by looking at 1 revenue side, but forgetting cost, would be half picture?
sorry I missed this question Ahtsham! I totally get where you’re coming from. In small caps like this, the market doesn’t always wait for perfect EPS; it tends to react to perceived potential first and then adjusts once the financials catch up. That’s part of what makes them high-risk, high reward.
Right now, we only have revenue numbers for Rocket Doctor, no detailed cost breakdown yet ....so, yeah, any model without that is half a picture. The upcoming August financials should give us a better sense of what consolidated margins look like post-acquisition.
If they can demonstrate ARR growing several times over and show clear progress toward cutting losses, the market could start to re-rate the story even before they hit net profitability. Until we see Rocket Doctor’s cost side, though, it’s really about weighing that upside potential against the execution risk.
Where to buy this security?
This is on the OTC as $TREIF, on the Canadian stock exchange as $TRUE, and 939 on German exchanges
Great article PQ I’ve been following #TREIF since you first alerted it 🙏
Well, i want expecting a 30% run in the first 15 minutes, but I'm glad people see the value here. I believe the company has everything they need to be successful.
how would the market react as per your experience? as net profit would still be negative 4-5m. market follows EPS in the long run, 24-->100m, means it will show 4x profit. Do we have Rocket Doctor bottom profit numbers or only revenue . we dont how much cost rocket doctor will have which will come here in consolidated financials? just by looking at 1 revenue side, but forgetting cost, would be half picture?
sorry I missed this question Ahtsham! I totally get where you’re coming from. In small caps like this, the market doesn’t always wait for perfect EPS; it tends to react to perceived potential first and then adjusts once the financials catch up. That’s part of what makes them high-risk, high reward.
Right now, we only have revenue numbers for Rocket Doctor, no detailed cost breakdown yet ....so, yeah, any model without that is half a picture. The upcoming August financials should give us a better sense of what consolidated margins look like post-acquisition.
If they can demonstrate ARR growing several times over and show clear progress toward cutting losses, the market could start to re-rate the story even before they hit net profitability. Until we see Rocket Doctor’s cost side, though, it’s really about weighing that upside potential against the execution risk.
XO
Penny